A promising two-punch therapy for Langerhans cell histiocytosis
Langerhans cell histiocytosis (LCH) is a rare cancer involving dendritic cells, a type of white blood cell that usually helps defend against infections. The current standard of care for LCH, chemotherapy, cures fewer than ...
Jun 29, 2021
0
7